QIAGEN CLC Genomics

Circulating Tumor Cell Detection and Analysis to Support Malignancy Designation, Tumor-of-Origin Identification, and Treatment Selection

676 views
October 25, 2023
Circulating tumor cells (CTCs) are cells that leave the primary tumor and are intravasated into the blood circulation system. A subset of those make it to other organs and are responsible for metastasis. iCellate’s CellMate platform is a CTC-based liquid biopsy for cancer cell enrichment, detection, and biomarker analysis via a simple blood draw.

In this seminar, you’ll learn:

From Helena Silva Cascales, senior scientist at iCellate Medical AB, how the isolation of whole-tumor cells provides a more comprehensive biomarker analysis, including genomic sequencing and multiplexed protein expression analysis.
From Kashyap Dave, principal scientist at iCellate Medical AB, how DNA from single CTCs can be amplified, sequenced, and analyzed to support malignancy designation and tissue of origin identification using classification analyses under development within Qiagen CLC Genomics Workbench.

Related videos

QIAGEN CLC Genomics

QIAGEN CLC Genomics Workbench 20 – scalable desktop software for NGS data analysis

5,074 views January 28, 2020

In this webinar, Leif Schauser, Ph.D., Director Product Management Genome...

QIAGEN CLC Genomics

De novo assembly, BLAST and genome finishing using QIAGEN CLC Genomics Workbench

1,880 views September 01, 2022

This webinar will introduce users to the tools available for short reads...

QIAGEN CLC Genomics

Long-read sequencing analysis in the QIAGEN CLC Genomics Workbench

1,739 views March 21, 2022

This tutorial is an introduction to working with the tools in the Long Read...

QIAGEN CLC Genomics

16S/18S/ITS sequencing analysis using CLC Genomics Workbench

1,622 views January 25, 2023

QIAGEN CLC Microbial Genomics Module provides tools and workflows for a broad...